MMH
ELOS

Menora Mivtachim Holdings’s Syneron Medical Ltd ELOS Stock Holding History

Menora Mivtachim Holdings’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-139,226
Closed -$1.47M – 84
2017
Q1 		$1.47M Sell
139,226
-375,520
-73% -$3.63M 0.07% 55
2016
Q4 		$4.32M Hold
514,746
– – 0.22% 58
2016
Q3 		$3.69M Buy
514,746
+20,811
+4% +$145K 0.2% 46
2016
Q2 		$3.8M Buy
+493,935
New +$3.52M 0.21% 46

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Menora Mivtachim Holdings's ELOS Position: Q2 2017 in Review

Menora Mivtachim Holdings sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 139,226 shares — an estimated $1.47M sold.

Menora Mivtachim Holdings first reported a position in ELOS in Q2 2016 and held it in 4 quarters. The position peaked at $4.32M in Q4 2016. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • Menora Mivtachim Holdings reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • Menora Mivtachim Holdings sold 139,226 Syneron Medical Ltd shares in Q2 2017, an estimated $1.47M.
  • Menora Mivtachim Holdings first reported a position in Syneron Medical Ltd in Q2 2016 and held it in 4 quarters.
  • Menora Mivtachim Holdings's Syneron Medical Ltd position peaked at $4.32M in Q4 2016.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Menora Mivtachim Holdings's 13F filing for Q2 2017, filed 31 Jul 2017.